This study aimed to evaluate the accuracy of magnetic resonance imaging (MRI) in the detection of deep myometrial invasion and cervical extension by endometrial carcinoma. This prospective study included 101 patients with histologically documented endometrial carcinoma, between July 1998 and April 2004. The findings of preoperative pelvic MRI were compared with histological diagnosis. From 101 cases studied by pelvic MRI, 43 were classified as deep myometrial invasion (50% of myometrium), where the pathological evaluation confirmed as having deep myometrial invasion. Cervical extension in the MRI study was found in 19 cases. Pathologic study found cervical extension and/or invasion in 31 cases including all cases identified by MRI. Th...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
Introduction and purpose of the study : Endometrial cancer is the third most common gynaecological c...
Background: Endometrial carcinoma is the fourth most common cancer in females and the most common ma...
Endometrial carcinoma is the most common gynecologic malignancy and accounts for 6% of all cancers i...
Endometrial carcinoma is the most common gynecologic malignancy and accounts for 6% of all cancers i...
Background: MRI is a useful modality for preoperative imaging in endometrial cancer. We report our e...
PURPOSE OF INVESTIGATION: Magnetic resonance imaging (MRI) has emerged as an important imaging modal...
Introduction: Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastases ...
Introduction: Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastases ...
PURPOSE OF INVESTIGATION: Magnetic resonance imaging (MRI) has emerged as an important imaging modal...
Introduction Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastas...
OBJECTIVES: To retrospectively evaluate the accuracy of magnetic resonance (MR) imaging for the pred...
To evaluate the usefulness of T2-weighed magnetic resonance images (MRI) in preoperative assessment ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
Introduction and purpose of the study : Endometrial cancer is the third most common gynaecological c...
Background: Endometrial carcinoma is the fourth most common cancer in females and the most common ma...
Endometrial carcinoma is the most common gynecologic malignancy and accounts for 6% of all cancers i...
Endometrial carcinoma is the most common gynecologic malignancy and accounts for 6% of all cancers i...
Background: MRI is a useful modality for preoperative imaging in endometrial cancer. We report our e...
PURPOSE OF INVESTIGATION: Magnetic resonance imaging (MRI) has emerged as an important imaging modal...
Introduction: Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastases ...
Introduction: Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastases ...
PURPOSE OF INVESTIGATION: Magnetic resonance imaging (MRI) has emerged as an important imaging modal...
Introduction Deep myometrial invasion (>= 50%) is a prognostic factor for lymph node metastas...
OBJECTIVES: To retrospectively evaluate the accuracy of magnetic resonance (MR) imaging for the pred...
To evaluate the usefulness of T2-weighed magnetic resonance images (MRI) in preoperative assessment ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
OBJECTIVE: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with ...
Introduction and purpose of the study : Endometrial cancer is the third most common gynaecological c...